J.P. Morgan Notebook Day 1: No Big Deals, But Plenty Of Pipeline, Commercial Highlights

 
• By Mandy Jackson, Jessica Merrill, and Andrew McConaghie

Daily round-up from the J.P. Morgan Healthcare Conference in San Francisco: There was no big M&A, but biopharma CEOs discussed deals they're pursuing. Also, Novartis's Zolgensma reimbursement insights, Sarepta's third DMD filing, Bristol's post-merger progress and more highlights.

Westin Hotel San Fransisco, CA
J.P. Morgan's Health Care Bash Kicked Off At The Westin St. Francis on 13 January. • Source: Shutterstock

More from Market Access

More from Pink Sheet